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granulocytes 4090/mm3, PLT 384.000/mm 3.
Conclusions: Due to the fact that the aplastic anemia is secondary to the treatment with 
Algocalmin occurred in a previously healthy young patient, the bone marrow rehabilitation was achieved 
with the right treatment.
After 6 months after the discharge, the patient had been declared completely cured having both 
aplastic anemia and systemic aspergillosis extinguished.
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Introduction: Multiple myeloma is a cancer of plasma cells, a type of white blood cell normally 
responsible for producing antibodies.
In multiple myeloma, collections of abnormal plasma cells accumulate in the bone marrow,
where they interfere with the production of normal blood cells. Most cases of multiple myeloma also 
feature the production of a paraprotein - an abnormal antibody which can cause bone lesions 
and hypercalcemia. Plasmacytoma refers to a tumour consisting of abnormal plasma cells that grows 
within the soft tissue or bony skeleton in the context of multiple myeloma disease.
Objective: We will present the case of a 56 years old female patient admitted in the Medical Clinic I -
Department of Hematology of Targu Mures, suffering from a rare hematological cancer - multiple 
myeloma of which onset was the appearance of a solitary extramedullary gigantic frontoparietal 
plasmacytoma which also did not responded at all to chemo-and radiotherapy treatment still increasing 
its size.
Clinical case: We monitored the patient over a period of 13 months and we will display the 
evolution chronologically.
Results: She was given 3 regimens of chemotherapy consisted in VAD, (Vincristine, 
Adriamycin, Dexamethasone), 7 regiments of PAD (Adriamycin, Epirubicin, Dexa.), one regimen of 
Velcade+Cytarabin+Dexamethasone in order to shrink the plasmacytoma but with no success. In the fall 
of 2015 she was presented at the oncology clinic for the administration of the radiotherapeutic regiments. 
After she recived a few radiotherapy still no reduction in the plasmacytoma volume. The oncologists 
stopped the therapy because the side effects were more significant than the improvements. The patient 
is currently hospitalized in our Hematology Clinic under the new treatment recently introduced with 
Caelix+Dexamethasone in order to reduce the level of plasma cells and the size of the frontoparietal 
plasmacytoma.
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Conclusions: Usually radiotherapy provides excellent local and regional control of 
plasmacytomas, but in our case it had no positive effect. The patient is having an evolution which leads 
to an continue worsening without obtaining remission, therefore the long-term prognosis is reserved 
while the medium one is favorable.
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Introduction: In pediatric practice topiramate is used alone or with other medicines to treat 
certain types of seizures and to prevent migraine headaches in adolescents 12 years and older. 
Clinical case: A14 years-old female was admitted into the ER Unit after voluntary ingestion of 
30 capsules (3000 mg) of topiramate. The drug was prescribed by her neurologist for migraines; the 
suicidal attempt was determined by a conflict with her mother. At admission she had dizziness, 
drowsiness, speech disturbances,abnormal coordination, vomiting and abdominal pain. Laboratory data 
showed severe anemia (Hb=4,3 g/dl), normochrome and normocytic, severe metabolic acidosis(HCO3 
- = 6,6 mEq/L), hypoglycemia (37 mg/dl), hypercloremia(Cl-=121,7 mEq/L), hypernatremia (Na+= 150 
mEq/L),hypokalemia (K+ =1,71 mEq/L). The treatment included gastric lavage, activated charcoal, 
intravenous fluids, bicarbonate and blood transfusions. The clinical status improved within 24 hours, Hb 
level raise to 13,8 g/dl and no other laboratory abnormalities were found. The medical records of the 
patient showed she has no anemia previously. A CT scan performed in order to exclude an organic cause 
for her headaches was normal. The patient was dismissed after 10 days in good general condition; she 
presented mild epigastric pain and leave the hospital with proton-pump inhibitor and pshychologic 
counceling recommendations. Subsequently she had several hospitalisations for depression and 
suicidary thoughts treated with sertraline and she is followed by a pediatric psychiatrist.
Conclusions: This is a particular case of voluntary topiramate intoxication with particular side 
effects as severe anemia and metabolic disturbances, followed by long-term behavioral consequences. 
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Introduction: Graves’ ophthalmopathy (GO) is an autoimmune inflammatory disorder 
Associated with thyroid disease which affects ocular and orbital tissues.
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